|
⚲
|
| Keyboard |
| Moura Andre V
✚
|
|
|---|---|
| CIK # | 0001631831 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001631831] | |
| 4 | [0001631831] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Moura Andre V | |
| Bellerophon Therapeutics LLC | |
| Avantor Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bellerophon Therapeutics LLC BLPH
Stock Option (right to buy) · derivative
|
2020-09-10 | Grant | 6,509 | $10.12 | 65,871 |
|
Bellerophon Therapeutics LLC BLPH
Stock Option (right to buy) · derivative
|
2019-09-26 | Grant | 46,266 | $0.00 | |
|
Bellerophon Therapeutics LLC BLPH
Common Stock
|
2018-06-21 | Grant | 15,411 | $0.00 | |
|
Bellerophon Therapeutics LLC BLPH
Stock Option (right to buy) · derivative
|
2018-06-05 | Grant | 38,216 | $2.27 | 86,750 |
|
Bellerophon Therapeutics LLC BLPH
Stock Option (right to buy) · derivative
|
2017-09-22 | Grant | 10,000 | $0.00 | |
|
Bellerophon Therapeutics LLC BLPH
Common Stock
|
2017-06-28 | Grant | 32,609 | $0.00 | |
|
Bellerophon Therapeutics LLC BLPH
Stock Option (right to buy) · derivative
|
2016-06-17 | Grant | 10,000 | $0.00 | |
|
Bellerophon Therapeutics LLC BLPH
Common Stock
|
2016-04-28 | Grant | 20,716 | $0.00 |